Aspects on the Mechanism of the 1-Phenyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]quinoxaline Formation
- 1 Department of Chemistry, Faculty of Science, Alexandria University, Ibrahimia, Egypt
- 2 Department of Chemistry, Faculty of Science, Alexandria University, Ibrahimia, Egypt
- 3 Department of Chemistry, Faculty of Science, Alexandria University, Ibrahimia, Egypt
- 4 Department of Chemistry, Faculty of Science, Alexandria University, Ibrahimia, Egypt
- 5 Department of Chemistry, Norwegian University of Science and Technology, Trondheim, Norway
Abstract
Condensation of D-glucose, o-phenylenediamine and N,N-benzylphenylhydrazine hydrochloride (NNBPHH) in a one-pot reaction, or condensation of 2-(D- arabino -tetritol-1-yl) quinoxaline and NNBPHH, gave 3-(D- erythro -glycerol-1- yl)-1-phenyl-1H-pyrazolo[3,4-b]quinoxaline. The structure of the latter was determined by 1H NMR spectroscopy and by synthesis using phenylhydrazine hydrochloride instead of NNBPHH. Condensation of D-glucose and 4,5-dichloro-o-phenylenediamine gave 6,7-dichloro-2-(D- arabino -tetritol-1-yl)quinoxaline, which upon condensation with NNBPHH gave the corresponding 6,7-dichloro-3-(D- erythro -glycerol-1-yl)-1-phenyl-1H-pyrazolo[3,4-b]quinoxaline. The structure and mechanism of formation of these compounds are discussed.
- M. A. Mostafa, “Aspects on Pyrazolo[3,4-b]quinoxaline Formation,” Bulletin of the Faculty of Science, Alexandria University, Vol. 29, No. 2-3, 1989, pp. 35-44.
- A. S. Shawali, M. M. Zayed and T. A. Farghaly, “Synthesis and Biological Activity of New 1H-Pyrazolo[3,4-b] quinoxalines (Flavazoles),” Journal of Heterocyclic Chemistry, Vol. 42, No. 2, 2005, pp. 185-189. doi:10.1002/jhet.5570420202
- N. P. Buu-Hoi, J. N. Vallat, G. Saint-Ruf and G. Lambelin, “Chimie, Physico-Chimie et Pharmacologie due Flavazole et de Quelques-Uns de Ses Derives Substitutes,” Chimie Therapeutique, Vol. 6, No. 4, 1971, pp. 245-250.
- Y. Kurasawa, M. Muramatsu, K. Yamazaki, S. Tajima, Y. Okamoto and A. Takada, “A Convenient Synthesis and Antifungal Activity of 1-Aryl-1H- and 1-Aryl-3-het-eroaryl- 1H-pyrazolo [3,4-b]quinoxalines,” Journal of Hetero-cyclic Chemistry, Vol. 23, No. 5, 1986, pp. 1379-1382. doi:10.1002/jhet.5570230524
- Y. Kurasawa, M. Mu-ramatsu, K. Yamazki, S. Tajima, Y. Okamoto and A. Takada, “A facile Synthesis of 1-Aryl-3- het-eroaryl-1H-pyrazolo[3,4-b]quinoxalines and Related Com-pounds with Antifungal Activity,” Journal of Heterocyclic Chemistry, Vol. 23, No. 5, 1986, pp. 1391-1394. doi:10.1002/jhet.5570230527
- M. M. Abbasi, S. M. El-Kousy, Y. E. El-Moghazy and S. El-Kafrawy, “Synthesis of Pyrazoloquinoxaline-C-Acyclic Nucleosides with Expected Antiviral Activity,” International Journal of Chemistry, Vol. 15, No. 2, 2005, pp. 77-84.
- M. A. Ortega, M. E. Montoya, B. Azrranz, A. Jaso, I. Aldana, S. Leclere, L. Meijer and A. Monge, “Pyrazolo [3,4-b]quinoxalines. A New Class of Cy-clin-Dependent Kinases Inhibitors,” Bioorganic and Medicinal Chemistry, Vol. 10, No. 7, 2002, pp. 2177-2184. doi:10.1016/S0968-0896(02)00069-X
- S. Young, M. K. Lee, Y. Kurasawa and A. Takada, “Synthesis and Evaluation of 1H-Pyrazolo[3,4-b]quinoxalines and 1-Aryl-3-quinoxalinyl-1,2,4-triazoles as Antibacterial Agents,” Journal of Heterocyclic Chemistry, Vol. 33, No. 6, 1996, pp. 1855-1858. doi:10.1002/jhet.5570330649
- A. Mongae, J. A. Palop, A. Ochoa de Retana, I. Urbasos and A. E. Fernandez, “New Quinoxalines and Pyrazolo [3,4-b]quinoxalines with An-tihypertensive Activity,” Ana- les de Quimica, Serie C: Quimica Organica y Bioquimica, Vol. 84, No. 3, 1988, pp. 364-366.
- H. Ohle and G. A. Melkonian, “1-Phenyl-3-(D-erythro- trioxypropyl)-flavazol. Die Konstitu-tion der Seitenkette,” Berichte der Deutschen Chemischen Ge-sellschaft, Vol. 74, No. 2, 1941, pp. 279-291. doi:10.1002/cber.19410740220